Ibrahim Yakoub-Agha, MD,PhD
University Hospital, Lille
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ibrahim Yakoub-Agha, MD,PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:41 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07609485 · Identifying Cellular and Molecular Determinants of Efficacy and Resistance in Patients Undergoing CAR-T TherapyUniversity Hospital, Lille · recruiting · Cancer, Hematologic Malignancy · principal investigator
- Ph1NCT06649227 · Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19University Hospital, Lille · recruiting · Relapsed Adult AML · principal investigator
- Ph2NCT05370976 · Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation.University Hospital, Lille · terminated · Cytomegalovirus Infections · principal investigator
- Ph2NCT03948529 · RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantationUniversity Hospital, Lille · terminated · Leukemia, Graft Failure · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.